FDA Guidance – Oversight of Clinical Investigations an RBM Approach to Monitoring (Infographic)

cyntegrity-infographic-fda-rbm-guidance

Click here for downloading the PDF version.

Based on the source: http://www.fda.gov/downloads/Drugs/…/Guidances/UCM269919.pdf

By | 2016-11-16T18:35:28+00:00 October 26, 2016|Blog|0 Comments

About the Author:

Professional in the integration of data-driven Risk-based Monitoring (RbM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, PharmaForum, PharmaDay, DGGF, etc. 10+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RbM research to new frontiers for CROs, pharma and biotech companies.

Leave A Comment

Upcoming Events

  1. SCDM 2018 ANNUAL CONFERENCE – Seattle

    September 23 - September 26
  2. PCT Europe 2018

    November 28 - November 29

Register Today!

Get Free Test Access